rs141040910

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000026218.9(PIGQ):​c.1555C>T​(p.Arg519Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000807 in 1,609,180 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R519H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0041 ( 5 hom., cov: 33)
Exomes 𝑓: 0.00047 ( 3 hom. )

Consequence

PIGQ
ENST00000026218.9 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -4.00

Publications

2 publications found
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
PIGQ Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 77
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036675036).
BP6
Variant 16-582906-C-T is Benign according to our data. Variant chr16-582906-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 456037.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00407 (619/152230) while in subpopulation AFR AF = 0.0136 (566/41526). AF 95% confidence interval is 0.0127. There are 5 homozygotes in GnomAd4. There are 294 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGQNM_004204.5 linkc.1617C>T p.Arg539Arg synonymous_variant Exon 11 of 11 ENST00000321878.10 NP_004195.2 Q9BRB3-2B2RAU6
PIGQNM_148920.4 linkc.1555C>T p.Arg519Cys missense_variant Exon 10 of 10 NP_683721.1 Q9BRB3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGQENST00000321878.10 linkc.1617C>T p.Arg539Arg synonymous_variant Exon 11 of 11 1 NM_004204.5 ENSP00000326674.6 Q9BRB3-2

Frequencies

GnomAD3 genomes
AF:
0.00406
AC:
618
AN:
152112
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0136
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00122
AC:
303
AN:
249194
AF XY:
0.000868
show subpopulations
Gnomad AFR exome
AF:
0.0158
Gnomad AMR exome
AF:
0.000783
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000107
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.000467
AC:
680
AN:
1456950
Hom.:
3
Cov.:
33
AF XY:
0.000369
AC XY:
267
AN XY:
724232
show subpopulations
African (AFR)
AF:
0.0153
AC:
511
AN:
33398
American (AMR)
AF:
0.000830
AC:
37
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25964
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39614
South Asian (SAS)
AF:
0.0000465
AC:
4
AN:
86084
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52342
Middle Eastern (MID)
AF:
0.000578
AC:
3
AN:
5188
European-Non Finnish (NFE)
AF:
0.0000622
AC:
69
AN:
1109602
Other (OTH)
AF:
0.000914
AC:
55
AN:
60154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
41
82
122
163
204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00407
AC:
619
AN:
152230
Hom.:
5
Cov.:
33
AF XY:
0.00395
AC XY:
294
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0136
AC:
566
AN:
41526
American (AMR)
AF:
0.00275
AC:
42
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67996
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00187
Hom.:
1
Bravo
AF:
0.00496
ESP6500AA
AF:
0.0168
AC:
74
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00146
AC:
177
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGQ: BP4, BS1 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epilepsy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
1.4
DANN
Benign
0.97
DEOGEN2
Benign
0.026
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0092
N
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
-4.0
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.58
N
REVEL
Benign
0.055
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.13
T
Polyphen
0.0050
B
Vest4
0.10
MVP
0.21
MPC
0.32
ClinPred
0.020
T
GERP RS
-6.6
Varity_R
0.10
gMVP
0.70
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141040910; hg19: chr16-632906; COSMIC: COSV50314158; COSMIC: COSV50314158; API